By Premiere Networks
Apr 16, 2021
BRETT: One of the areas of this audience that you and Rush appreciated are the owners and those operators of small businesses in this business. Now, in Rush s honor, you ve created the Great American Business Award, and you re taking nominations. How s the response been so far?
KATHRYN: It s been huge. We ve received many, many nominations over these last weeks. As you mentioned in the beginning, Rush wanted to start this, actually, at the start of this year. But unfortunately, he couldn t. So he wanted to recognize small businesses throughout the country that really make our country work, and so we re continuing it on in his honor. But the response has been quite overwhelming and wonderful at the same time.
Kathryn Interviews Finalists for the Great American Business Award
Apr 16, 2021
BRETT: One of the areas of this audience that you and Rush appreciated are the owners and those operators of small businesses in this business. Now, in Rush’s honor, you’ve created the Great American Business Award, and you’re taking nominations. How’s the response been so far?
KATHRYN: It’s been huge. We’ve received many, many nominations over these last weeks. As you mentioned in the beginning, Rush wanted to start this, actually, at the start of this year. But unfortunately, he couldn’t. So he wanted to recognize small businesses throughout the country that really make our country work, and so we’re continuing it on in his honor. But the response has been quite overwhelming and wonderful at the same time.
Credit: NJIT
There is no sustainable cure at present for osteoarthritis, the most common chronic musculoskeletal disorder of the joints. And while joint replacements are successful treatments for older patients with already reduced mobility, they hold less promise for younger patients, with failure in the long-term nearly guaranteed. Biomaterial engineers propose another solution: restoring the damaged tissue itself. The gap between supply and demand for transplantable tissues and organs is continuously increasing, says Murat Guvendiren, an assistant professor of chemical and materials engineering who is developing biomaterials designed to enable the production of fully functional, human-scale tissues and organs that are capable of replacing failed organs. Known as bioinks - hydrogels seeded with live human cells that are 3D-printed in the lab - these materials could potentially be used to construct highly complex and patient-specific tissues and organs, as well as tissue interfa